Brief: Novakand Pharma Q4 Operating Loss At SEK 5 Mln
20/02/2026 07:11
Feb 20 (Reuters) - Novakand Pharma AB NOVKAN.ST: Q4 NET SALES AMOUNTED TO 0 MSEK Q4 OPERATING RESULT WAS -5.0 MSEK DIVIDEND PROPOSAL: NO DIVIDEND Source text: ID:nMFNcbX7DF Further company coverage: NOVKAN.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Novakand Pharma AB
See all newsBrief: Nasdaq Decides To Delist Novakand From First North Growth Market
Brief: Novakand Pharma Extends Peter Selin's CEO Employment
Brief: Novakand Board Proposes New Business Direction, Relisting
Brief: Novakand Pharma Evaluates Options After Decision Not To Execute Reverse Take Over
Brief: Nasdaq Rejects Novakand's Application For Continued Listing